ProKidney Corp. (PROK)
NASDAQ: PROK · Real-Time Price · USD
2.240
0.00 (0.00%)
At close: Dec 31, 2025, 4:00 PM EST
2.315
+0.075 (3.36%)
Pre-market: Jan 2, 2026, 8:06 AM EST
ProKidney Market Cap
ProKidney has a market cap or net worth of $673.87 million as of January 2, 2026. Its market cap has increased by 193.37% in one year.
Market Cap
673.87M
Enterprise Value
406.38M
1-Year Change
193.37%
Ranking
Category
Stock Price
$2.24
Market Cap Chart
Since June 30, 2021, ProKidney's market cap has increased from $50.55M to $673.87M, an increase of 1,233.07%. That is a compound annual growth rate of 77.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 31, 2025 | 317.06M | 46.61% |
| Dec 31, 2024 | 216.27M | 80.97% |
| Dec 29, 2023 | 119.50M | -71.69% |
| Dec 30, 2022 | 422.17M | 33.72% |
| Dec 31, 2021 | 315.71M | 524.55% |
| Jun 30, 2021 | 50.55M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 966.79B |
| Johnson & Johnson | 498.51B |
| AbbVie | 406.04B |
| UnitedHealth Group | 300.88B |
| AstraZeneca | 287.28B |
| Novartis AG | 266.00B |
| Merck & Co. | 263.24B |
| Novo Nordisk | 227.63B |